Report Detail
Europe High-Flow Nasal Cannula Market to 2027 - Regional Analysis and Forecasts by Component (Air Oxygen Blender, Nasal Cannula, Heated Inspiratory Circuit, and Active Humidifier); Application (Bronchiectasis, Acute Respiratory Failure, Acute Heart Failure, and Chronic Obstructive Pulmonary Disease); End User (Ambulatory Care Centers, Hospitals and Long-Term Care Centers) and Country
- RnM3876500 |
- 07 February, 2020 |
- Global |
- 139 Pages |
- The Insight Partners |
- Other
The European high-flow nasal cannula market is expected to reach US$ 3,298.04 Mn in 2027 from US$ 1,327.65 Mn in 2018. The market is projected to grow with a CAGR of 10.8% from 2019-2027.
The growth of the market is majorly contributed by the increased lung cancer conferences across Europe, and growing asthma cases in adults in children are expected to boost the market growth over the years. However, side effects associated with high flow nasal cannula is likely to have a negative impact on the growth of the market in the coming years.
Asthma is the lifelong chronic inflammatory disorder of the airways that affects adults and children of all ages. According to the European Respiratory Society, Asthma is a chronic inflammatory disease of the airways that causes recurring episodes of wheezing, breathlessness, chest tightness, and coughing. It is the most common disease that affects people of all ages in all countries in Europe. As per data published, about 30 million adults less than 45 old, and children have asthma in their lifetime. The incidence of asthma has been increased substantially in Europe, at some time between 1950 and 2000. As per the data obtained from the European Community Respiratory Health Survey and local health institutions, the prevalence in adults is highest in the UK (10% - 13%).
In 2018, the UK high-flow nasal cannula market held the largest share of the Europe high-flow nasal cannula market. The hospital segment expected to dominate the Europe high-flow nasal cannula market. Additionally, this segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027. Similarly, in 2018 the active humidifier segment held the major market share among the component segments.
In 2018, the active humidifier segment held a largest market share of the high-flow nasal cannula market, by Component. The active humidifier is expected to dominate its market share in 2027 because it provides moisture and heat to respiratory gas through an electrically powered humidifier. The active humidifier segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.
Chronic Obstructive Pulmonary Disease segment a largest market share of the high-flow nasal cannula market, by application in 2018. However, bronchiectasis segment expected to have largest market in 2027 because diagnosis of bronchiectasis has been growing consistently since 2001 and its prevalence is more in elder population.
Hospital segment held the largest market share of the high-flow nasal cannula market, by end user, owing to its benefits offered, such as proper patient-centric care, availability of reimbursement facilities.
Some of the major primary and secondary sources for drug delivery systems included in the report are Chest Research Foundation, The European Environment Agency, the German Centre for Addiction Issues, etc.
TABLE OF CONTENTS
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
2. Europe High-Flow Nasal Cannula Market – Key Takeaways
3. Europe High-Flow Nasal Cannula Market – Market Landscape
- 3.1 Overview
- 3.2 Market Segmentation
- 3.2.1 Europe High-Flow Nasal Cannula Market – By Component
- 3.2.2 Europe High-Flow Nasal Cannula Market – By Application
- 3.2.3 Europe High-Flow Nasal Cannula Market – By End User
- 3.2.4 Europe High-Flow Nasal Cannula Market – By Europe Countries
- 3.3 PEST Analysis
4. Europe High-Flow Nasal Cannula Market - Key Market Dynamics
- 4.1 Key Market Drivers
- 4.1.1 Increasing Lung Cancer Conferences Across Europe
- 4.1.2 Growing Asthma Cases in Adults and Children
- 4.2 Key Market Restraints
- 4.2.1 Side Effects Associated with High Flow Nasal Cannula
- 4.3 Key Market Opportunity
- 4.3.1 Growing Geriatric Population
- 4.4 Future Trend
- 4.4.1 Increasing Acceptance of Home Oxygen Therapy
- 4.5 Impact Analysis
5. High-Flow Nasal Cannula Market – Europe Analysis
- 5.1 Europe High-Flow Nasal Cannula Market Revenue Forecasts and Analysis
- 5.2 Market positioning
- 5.3 Performance of Key Players
- 5.3.1 Fisher & Paykel Healthcare Limited
- 5.3.2 ResMed
6. Europe High-Flow Nasal Cannula Market Analysis – By Component
- 6.1 Overview
- 6.2 Component market Revenue and Forecasts Analysis (US$ Mn)
- 6.3 Air Oxygen Blender
- 6.3.1 Overview
- 6.3.2 Europe Air Oxygen Blender Market Revenue and Forecast to 2027 (US$ Mn)
- 6.4 Nasal Cannula
- 6.4.1 Overview
- 6.4.2 Europe Nasal Cannula Market Revenue and Forecast to 2027 (US$ Mn)
- 6.5 Heated Inspiratory Circuit
- 6.5.1 Overview
- 6.5.2 Europe Heated Inspiratory Circuit Market Revenue and Forecast to 2027 (US$ Mn)
- 6.6 Active Humidifier
- 6.6.1 Overview
- 6.6.2 Europe Active Humidifier Market Revenue and Forecast to 2027 (US$ Mn)
7. Europe High-Flow Nasal Cannula Market Analysis – By Application
- 7.1 Overview
- 7.2 Europe High-Flow Nasal Cannula Market, by Application 2018 & 2027 (%)
- 7.3 Bronchiectasis
- 7.3.1 Overview
- 7.3.2 Europe Bronchiectasis Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4 Acute Respiratory Failure
- 7.4.1 Overview
- 7.4.2 Europe Acute Respiratory Failure Market Revenue and Forecast to 2027 (US$ Mn)
- 7.5 Acute Heart Failure
- 7.5.1 Overview
- 7.5.2 Europe Acute Heart Failure Market Revenue and Forecast to 2027 (US$ Mn)
- 7.6 Chronic Obstructive Pulmonary Disease
- 7.6.1 Overview
- 7.6.2 Europe Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2027 (US$ Mn)
8. Europe High-Flow Nasal Cannula Market Analysis – By End User
- 8.1 Overview
- 8.2 Europe High-Flow Nasal Cannula Market, by Applicaton 2018 & 2027 (%)
- 8.3 Ambulatory Surgical Centers
- 8.3.1 Overview
- 8.3.2 Europe Ambulatory Surgical Centers Market Revenue and Forecast to 2027 (US$ Mn)
- 8.4 Hospitals
- 8.4.1 Overview
- 8.4.2 Europe Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
- 8.5 Long-Term Care Centers
- 8.5.1 Overview
- 8.5.2 Europe Long-Term Care Centers Market Revenue and Forecast to 2027 (US$ Mn)
9. Europe High-Flow Nasal Cannula Market Revenue And Forecasts To 2027
- 9.1 Europe High-Flow Nasal Cannula Market
- 9.1.1 Overview
- 9.1.2 Europe High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.3 Europe High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
- 9.1.4 Europe High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.1.5 Europe High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 9.1.6 Europe High-Flow Nasal Cannula Market Revenue and Forecasts to 2027, By Country (%)
- 9.1.7 Germany
- 9.1.7.1 Germany High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.7.2 Germany High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
- 9.1.7.3 Germany High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.1.7.4 Germany High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 9.1.8 UK
- 9.1.8.1 UK High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.8.2 UK High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
- 9.1.8.3 UK High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.1.8.4 UK High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 9.1.9 France
- 9.1.9.1 France High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.9.2 France High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
- 9.1.9.3 France High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.1.9.4 France High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 9.1.10 Spain
- 9.1.10.1 Spain High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.10.2 Spain High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
- 9.1.10.3 Spain High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.1.10.4 Spain High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 9.1.11 Italy
- 9.1.11.1 Italy High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.11.2 Italy High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
- 9.1.11.3 Italy High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.1.11.4 Italy High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10. High-Flow Nasal Cannula Market –Industry Landscape
- 10.1 Overview
- 10.1.1 Recent Developments by Players in the High-Flow Nasal Cannula Market
11. High-Flow Nasal Cannula Market–Key Company Profiles
- 11.1 Fisher & Paykel Healthcare Limited
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Financial Overview
- 11.1.4 Product Portfolio
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
- 11.2 ResMed.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Financial Overview
- 11.2.4 Product Portfolio
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
- 11.3 Teleflex Incorporated
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Financial Information
- 11.3.4 Product Portfolio
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
- 11.4 Hamilton Company
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Financial Overview
- 11.4.4 Product Portfolio
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
- 11.5 Great Group Medical Co., Ltd.
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Financial Information
- 11.5.4 Product Portfolio
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
- 11.6 Salter Labs (SunMed, LLC)
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Financial Overview
- 11.6.4 Product Portfolio
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
- 11.7 TNI medical AG.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Financial Overview
- 11.7.4 Product Portfolio
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
- 11.8 Flexicare (Group) Limited
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Financial Overview
- 11.8.4 Product Portfolio
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
- 11.9 Vapotherm
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Financial Overview
- 11.9.4 Product Portfolio
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
- 11.10 MEK-ICS CO., LTD.
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Financial Overview
- 11.10.4 Solution Portfolio
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
12. Appendix
- 12.1 About The Insight Partners
- 12.2 Glossary of Terms
- 12.3 Methodology
- 12.4 Coverage
- 12.5 Secondary Research
Summary:
Get latest Market Research Reports on Europe High-Flow Nasal Cannula . Industry analysis & Market Report on Europe High-Flow Nasal Cannula is a syndicated market report, published as Europe High-Flow Nasal Cannula Market to 2027 - Regional Analysis and Forecasts by Component (Air Oxygen Blender, Nasal Cannula, Heated Inspiratory Circuit, and Active Humidifier); Application (Bronchiectasis, Acute Respiratory Failure, Acute Heart Failure, and Chronic Obstructive Pulmonary Disease); End User (Ambulatory Care Centers, Hospitals and Long-Term Care Centers) and Country . It is complete Research Study and Industry Analysis of Europe High-Flow Nasal Cannula market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
